NASDAQ:AVIR | Cash Flow Statement | Atea Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$32.93M
2026-03-31-$45.44M-$46.39M$29.74M$257,000.00
2025-12-31-$44.87M-$28.22M$46.59M$0.00$0.00
2025-09-30-$42.05M
2025-06-30-$37.16M
2025-03-31-$34.27M-$30.56M$85.61M-$347,000.00
2024-12-31-$33.54M-$30.4M-$3.37M$0.00
2024-09-30-$31.15M
2024-06-30-$40.52M
2024-03-31-$63.17M-$39.87M$56.8M$150,000.00
2023-12-31-$39.16M-$21.83M$27.77M$0.00
2023-09-30-$33.14M
2023-06-30-$28.18M
2023-03-31-$35.47M-$29.85M$24.48M$165,000.00
2022-12-31-$34.43M-$21.55M$0.00$33.49M$0.00
2022-09-30-$8.07M
2022-06-30-$31.34M
2022-03-31-$42.08M-$59.01M$44,000.00-$44,000.00$223,000.00
2021-12-31$117.13M-$75.42M$142,000.00
2021-09-30-$28.19M
2021-06-30$1.54M
2021-03-31$30.71M-$16.84M$471,000.00
2020-12-31$20.66M$318.52M$5,000.00-$5,000.00$426.22M
2020-09-30-$17.62M
2020-06-30-$9.99M
2020-03-31-$3.99M-$4.51M-$6,000.00
2019-12-31-$4.66M-$3.94M$0.00$0.00
2019-09-30-$3.63M
2019-06-30-$3.55M
2019-03-31-$2.19M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$158.35M-$132.03M$188.79M$25.52M-$25.75M
2024-12-31-$168.39M-$135.5M$56.11M$0.00$267,000.00
2023-12-31-$135.96M-$85.4M$40.3M$257,000.00
2022-12-31-$115.91M-$120.98M$1.94M-$455.41M$370,000.00
2021-12-31$121.19M-$87.01M$4,000.00-$4,000.00$1.47M
2020-12-31-$10.95M$296.73M$26,000.00-$26,000.00$531.75M
2019-12-31-$14.03M-$12.83M$2,000.00-$2,000.00
2018-12-31-$9.06M-$7.91M$12,000.00-$12,000.00$27.48M